NeuragenPain Relief (Origin Biomed Inc.)


Welcome to the PulseAid listing for the Neuragen drug offered from Origin Biomed Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Origin Biomed Inc.
NON-PROPRIETARY NAME: Aconitum napellus, Hypericum perforatum, Lycopodium clavatum, Phosphorus, Rhus toxicodendron, Secale cornutum
SUBSTANCE NAME: ACONITUM NAPELLUS; HYPERICUM PERFORATUM; LYCOPODIUM CLAVATUM SPORE; TOXICODENDRON PUBESCENS LEAF; CLAVICEPS PURPUREA SCLEROTIUM; PHOSPHORUS
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: CREAM
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2011-08-01
END MARKETING DATE: 0000-00-00


Neuragen Pain Relief HUMAN OTC DRUG Details:

Item DescriptionNeuragen Pain Relief from Origin Biomed Inc.
LABELER NAME: Origin Biomed Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 12; 12; 12; 12; 12; 12([hp_C]/113g; [hp_C]/113g; [hp_C]/113g; [hp_C]/113g; [hp_C]/113g; [hp_C]/113g)
START MARKETING DATE: 2011-08-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 15377-010_9ba499c2-c23e-481d-9fa9-8862f043887a
PRODUCT NDC: 15377-010
APPLICATION NUMBER:

Other ACONITUM NAPELLUS; HYPERICUM PERFORATUM; LYCOPODIUM CLAVATUM SPORE; TOXICODENDRON PUBESCENS LEAF; CLAVICEPS PURPUREA SCLEROTIUM; PHOSPHORUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Origin Biomed Inc.Neuragen